Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Metastatic Dedifferentiated Liposarcoma · Metastatic Undifferentiated Pleomorphic Sarcoma · Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 · Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 · Unresectable Dedifferentiated Liposarcoma · Unresectable Undifferentiated Pleomorphic Sarcoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Mahesh Seetharam)
  • Banner University Medical Center - Tucson, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Anna Roshal)
  • University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Anna Roshal)
  • Kaiser Permanente Dublin, Dublin, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Fremont, Fremont, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente Fresno Orchard Plaza, Fresno, California, United States

    Contact: Study coordinator (Site Public Contact) · 833-574-2273
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Fresno, Fresno, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • UC San Diego Moores Cancer Center, La Jolla, California, United States

    Contact: Study coordinator (Site Public Contact) · cancercto@ucsd.edu · 858-822-5354
    Contact: Principal Investigator (Hirotaka Miyashita)
  • Keck Medicine of USC Koreatown, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 213-388-0908
    Contact: Principal Investigator (Mark Agulnik)
  • Los Angeles General Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · uscnorrisinfo@med.usc.edu · 323-865-0451
    Contact: Principal Investigator (Mark Agulnik)
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Mark Agulnik)
  • Cedars-Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · Cancer.trial.info@cshs.org · 310-423-2133
    Contact: Principal Investigator (James S. Hu)
  • Kaiser Permanente- Modesto MOB II, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Modesto, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Mark Agulnik)
  • Kaiser Permanente-Oakland, Oakland, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Stanford Cancer Institute Palo Alto, Palo Alto, California, United States

    Contact: Study coordinator (Site Public Contact) · ccto-office@stanford.edu · 650-498-7061
    Contact: Principal Investigator (Nam Bui)
  • VA Palo Alto Health Care System, Palo Alto, California, United States

  • Huntington Memorial Hospital, Pasadena, California, United States

    Contact: Study coordinator (Site Public Contact) · 626-535-2420
    Contact: Principal Investigator (James S. Hu)
  • Kaiser Permanente-Roseville, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente Downtown Commons, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-South Sacramento, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • UCSF Medical Center-Mission Bay, San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · cancertrials@ucsf.edu · 877-827-3222
    Contact: Principal Investigator (Varun Monga)
  • Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente San Leandro, San Leandro, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser San Rafael-Gallinas, San Rafael, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-South San Francisco, South San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Vallejo, Vallejo, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • UCHealth University of Colorado Hospital, Aurora, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 720-848-0650
    Contact: Principal Investigator (Breelyn A. Wilky)
  • Poudre Valley Hospital, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-297-6150
    Contact: Principal Investigator (Breelyn A. Wilky)
  • Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · ecog.rss@jimmy.harvard.edu
    Contact: Principal Investigator (Breelyn A. Wilky)
  • UCHealth Greeley Hospital, Greeley, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · ecog.rss@jimmy.harvard.edu
    Contact: Principal Investigator (Breelyn A. Wilky)
  • Medical Center of the Rockies, Loveland, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-203-7083
    Contact: Principal Investigator (Breelyn A. Wilky)
  • Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Hari A. Deshpande)
  • Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Hari A. Deshpande)
  • Smilow Cancer Hospital Care Center at Greenwich, Greenwich, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Hari A. Deshpande)
  • Smilow Cancer Hospital Care Center - Guilford, Guilford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Hari A. Deshpande)
  • Yale University, New Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Hari A. Deshpande)
  • Smilow Cancer Hospital Care Center at Long Ridge, Stamford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Hari A. Deshpande)
  • Smilow Cancer Hospital-Torrington Care Center, Torrington, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Hari A. Deshpande)
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Hari A. Deshpande)
  • Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Hari A. Deshpande)
  • Smilow Cancer Hospital Care Center - Waterford, Waterford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Hari A. Deshpande)
  • Beebe South Coastal Health Campus, Millville, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • Helen F Graham Cancer Center, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Medical Oncology Hematology Consultants PA, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Beebe Health Campus, Rehoboth Beach, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Emily E. Jonczak)
  • UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Emily E. Jonczak)
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Emily E. Jonczak)
  • UF Health Cancer Institute - Gainesville, Gainesville, Florida, United States

    Contact: Study coordinator (Site Public Contact) · cancer-center@ufl.edu · 352-273-8010
    Contact: Principal Investigator (Leighton A. Elliott)
  • UM Sylvester Comprehensive Cancer Center at Hollywood, Hollywood, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Emily E. Jonczak)
  • Mayo Clinic in Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Mahesh Seetharam)
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Emily E. Jonczak)
  • UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Emily E. Jonczak)
  • University of Miami Sylvester Comprehensive Cancer Center at Sole Mia, North Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · kginnity@med.miami.edu
    Contact: Principal Investigator (Emily E. Jonczak)
  • UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Emily E. Jonczak)
  • Moffitt Cancer Center - McKinley Campus, Tampa, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Mauricio Fernando Silva Almeida Ribeiro)
  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Mauricio Fernando Silva Almeida Ribeiro)
  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (Kenneth Cardona)
  • Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · shelley.a.clark@kp.org · 808-432-5195
    Contact: Principal Investigator (Tatjana Kolevska)
  • Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States

  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States

  • Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho, United States

  • Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Advocate Outpatient Center - Aurora, Aurora, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aah.org
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Advocate Good Shepherd Hospital, Barrington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-842-4847
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Illinois CancerCare-Bloomington, Bloomington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Canton, Canton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Carthage, Carthage, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Centralia Oncology Clinic, Centralia, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancer@northwestern.edu · 312-695-1301
    Contact: Principal Investigator (Seth M. Pollack)
  • University of Illinois, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-355-3046
    Contact: Principal Investigator (Vijayakrishna K. Gadi)
  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Janet Chin)
  • Advocate Illinois Masonic Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 773-296-5360
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • AMG Crystal Lake - Oncology, Crystal Lake, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocate.com · 630-929-6129
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Seth M. Pollack)
  • Illinois CancerCare-Dixon, Dixon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 815-285-7800
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Good Samaritan Hospital, Downers Grove, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Barbara.barhamand@advocatehealth.com · 630-275-1270
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Crossroads Cancer Center, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Sherman Hospital, Elgin, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-429-2907
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Elmhurst Memorial Hospital, Elmhurst, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Jrohde@emhc.org · 630-758-5460
    Contact: Principal Investigator (Samir D. Undevia)
  • Illinois CancerCare-Eureka, Eureka, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Galesburg, Galesburg, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Seth M. Pollack)
  • Northwestern Medicine Glenview Outpatient Center, Glenview, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (Seth M. Pollack)
  • Northwestern Medicine Grayslake Outpatient Center, Grayslake, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (Seth M. Pollack)
  • Ingalls Memorial Hospital, Harvey, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@ingalls.org · 708-915-4673
    Contact: Principal Investigator (James A. Wallace)
  • Advocate South Suburban Hospital, Hazel Crest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 708-799-9995
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancertrials@northwestern.edu
    Contact: Principal Investigator (Seth M. Pollack)
  • AMG Libertyville - Oncology, Libertyville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocatehealth.com · 630-929-6129
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Condell Memorial Hospital, Libertyville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocatehealth.com · 630-929-6129
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Illinois CancerCare-Macomb, Macomb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Edward Hospital/Cancer Center, Naperville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 630-646-6075
    Contact: Principal Investigator (Samir D. Undevia)
  • UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Janet Chin)
  • Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Christ Medical Center, Oak Lawn, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-323-8622
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Northwestern Medicine Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (Seth M. Pollack)
  • University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Janet Chin)
  • Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Lutheran General Hospital, Park Ridge, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-384-3621
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Illinois CancerCare-Pekin, Pekin, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Peoria, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Peru, Peru, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Edward Hospital/Cancer Center?Plainfield, Plainfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Cancerresearch@edward.org · 630-646-6075
    Contact: Principal Investigator (Samir D. Undevia)
  • Illinois CancerCare-Princeton, Princeton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 217-545-7929
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-444-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Memorial Hospital, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · pallante.beth@mhsil.com · 217-528-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Seth M. Pollack)
  • Illinois CancerCare - Washington, Washington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • UChicago Medicine Northwest Indiana, Crown Point, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 855-702-8222
    Contact: Principal Investigator (Janet Chin)
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · iutrials@iu.edu · 317-278-5632
    Contact: Principal Investigator (Samantha A. Armstrong)
  • Sidney and Lois Eskenazi Hospital, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · iutrials@iu.edu · 317-278-5632
    Contact: Principal Investigator (Samantha A. Armstrong)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Saint Anthony Regional Hospital, Carroll, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · sbenson@iora.org · 515-689-7658
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Broadlawns Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-282-2200
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Healthcare Mission Cancer and Blood - Fort Dodge, Fort Dodge, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · trials@missioncancer.com · 515-282-2921
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 800-237-1225
    Contact: Principal Investigator (John M. Rieth)
  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · 502-562-3429
    Contact: Principal Investigator (Rohit Kumar)
  • UofL Health Medical Center Northeast, Louisville, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · ctoinfo@louisville.edu · 502-852-2755
    Contact: Principal Investigator (Rohit Kumar)
  • Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana, United States

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-442-3324
    Contact: Principal Investigator (Candace L. Haddox)
  • University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CancerAnswerLine@med.umich.edu · 800-865-1125
    Contact: Principal Investigator (Rashmi Chugh)
  • Henry Ford Cancer Institute-Downriver, Brownstown, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Marian R. Girgis)
  • Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Marian R. Girgis)
  • Henry Ford Medical Center-Fairlane, Dearborn, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Marian R. Girgis)
  • Henry Ford Hospital, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Marian R. Girgis)
  • Allegiance Health, Jackson, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Marian R. Girgis)
  • Henry Ford Medical Center-Columbus, Novi, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Marian R. Girgis)
  • Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Marian R. Girgis)
  • Henry Ford Wyandotte Hospital, Wyandotte, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · nhay@hfhs.org
    Contact: Principal Investigator (Marian R. Girgis)
  • Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 218-333-5000
    Contact: Principal Investigator (Daniel Almquist)
  • Mercy Hospital, Coon Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Essentia Health - Deer River Clinic, Deer River, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Cancer Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Fairview Southdale Hospital, Edina, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Mahesh Seetharam)
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Regions Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • United Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Essentia Health Sandstone, Sandstone, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Virginia Clinic, Virginia, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Mia C. Weiss)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Mia C. Weiss)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Mia C. Weiss)
  • Community Hospital of Anaconda, Anaconda, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Billings Clinic Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · research@billingsclinic.org · 800-996-2663
    Contact: Principal Investigator (John M. Schallenkamp)
  • Bozeman Health Deaconess Hospital, Bozeman, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Benefis Sletten Cancer Institute, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Logan Health Medical Center, Kalispell, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Community Medical Center, Missoula, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Nebraska Medicine-Bellevue, Bellevue, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Omar K. Abughanimeh)
  • Nebraska Medicine-Village Pointe, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-559-5600
    Contact: Principal Investigator (Omar K. Abughanimeh)
  • University of Nebraska Medical Center, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Omar K. Abughanimeh)
  • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, United States

    Contact: Study coordinator (Site Public Contact) · cancer.research.nurse@dartmouth.edu · 800-639-6918
    Contact: Principal Investigator (Garrett T. Wasp)
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Robert Maki)
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Robert Maki)
  • University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · HSC-ClinicalTrialInfo@salud.unm.edu · 505-925-0348
    Contact: Principal Investigator (David Savage)
  • Roswell Park Cancer Institute, Buffalo, New York, United States

    Contact: Study coordinator (Site Public Contact) · askroswell@roswellpark.org · 800-767-9355
    Contact: Principal Investigator (Ajay Gupta)
  • Northwell Health/Center for Advanced Medicine, Lake Success, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Tony Philip)
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@nyulangone.org
    Contact: Principal Investigator (Matthew Ingham)
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Robert Maki)
  • University of Rochester, Rochester, New York, United States

    Contact: Study coordinator (Site Public Contact) · 585-275-5830
    Contact: Principal Investigator (Adrienne I. Victor)
  • Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Michelle Sterpi)
  • Montefiore Medical Center - Moses Campus, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Michelle Sterpi)
  • Memorial Sloan Kettering Nassau, Uniondale, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Robert Maki)
  • Duke University Medical Center, Durham, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-275-3853
    Contact: Principal Investigator (Richard F. Riedel)
  • Sanford Bismarck Medical Center, Bismarck, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Broadway Medical Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-234-6161
    Contact: Principal Investigator (Daniel Almquist)
  • UH Seidman Cancer Center at UH Avon Health Center, Avon, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 800-641-2422
    Contact: Principal Investigator (Ankit Mangla)
  • UHHS-Chagrin Highlands Medical Center, Beachwood, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Ankit Mangla)
  • Miami Valley Hospital South, Centerville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Case Western Reserve University, Cleveland, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Ankit Mangla)
  • Cleveland Clinic Foundation, Cleveland, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · TaussigResearch@ccf.org · 866-223-8100
    Contact: Principal Investigator (Dale R. Shepard)
  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (Marium Husain)
  • Miami Valley Hospital, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Premier Blood and Cancer Center, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-276-8320
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Miami Valley Hospital North, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Miami Valley Cancer Care and Infusion, Greenville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-569-7515
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Upper Valley Medical Center, Troy, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Minh Phan)
  • Saint Alphonsus Cancer Care Center-Ontario, Ontario, Oregon, United States

  • Oregon Health and Science University, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · trials@ohsu.edu · 503-494-1080
    Contact: Principal Investigator (Christopher W. Ryan)
  • Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · PMCancerResearch@pennmedicine.upenn.edu · 215-349-8245
    Contact: Principal Investigator (Daniel Lefler)
  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Atrayee B. Mallick)
  • Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 215-728-4790
    Contact: Principal Investigator (Teresa Lee)
  • Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 877-284-2000
    Contact: Principal Investigator (Larisa Greenberg)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Melissa A. Burgess)
  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · hcc-clinical-trials@musc.edu · 843-792-9321
    Contact: Principal Investigator (Christopher A. Rangel)
  • Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicTrialsSF@sanfordhealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsSF@SanfordHealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · 800-811-8480
    Contact: Principal Investigator (Elizabeth J. Davis)
  • M D Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · askmdanderson@mdanderson.org · 877-632-6789
    Contact: Principal Investigator (Elise F. Nassif)
  • University of Virginia Cancer Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303
    Contact: Principal Investigator (Ludimila Cavalcante)
  • VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · CTOclinops@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Andrew Poklepovic)
  • ThedaCare Regional Cancer Center, Appleton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ResearchDept@thedacare.org · 920-364-3604
    Contact: Principal Investigator (Matthias Weiss)
  • Duluth Clinic Ashland, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Aurora Saint Luke's South Shore, Cudahy, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Aurora Health Care Germantown Health Center, Germantown, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Aurora Cancer Care-Grafton, Grafton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Aurora BayCare Medical Center, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-3666
    Contact: Principal Investigator (John A. Charlson)
  • Aurora Sinai Medical Center, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · research.institute@phci.org
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7878
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Aurora Cancer Care-Racine, Racine, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Aurora Medical Center in Summit, Summit, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7632
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Chanda.miller@phci.org · 262-928-5539
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Aurora West Allis Medical Center, West Allis, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Sigrun Hallmeyer)
  • Marshfield Medical Center - Weston, Weston, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta, Canada

    Contact: Study coordinator (Site Public Contact) · ctsucontact@westat.com · 888-823-5923
    Contact: Principal Investigator (Xiaolan Feng)
  • Cross Cancer Institute, Edmonton, Alberta, Canada

    Contact: Study coordinator (Site Public Contact) · 780-432-8500
    Contact: Principal Investigator (Branawan Gowrishankar)
  • CancerCare Manitoba, Winnipeg, Manitoba, Canada

    Contact: Study coordinator (Site Public Contact) · ctu_web@cancercare.mb.ca · 866-561-1026
    Contact: Principal Investigator (Shantanu Banerji)
  • Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada

    Contact: Study coordinator (Site Public Contact) · 905-387-9495
    Contact: Principal Investigator (Courtney Coschi)
  • Ottawa Hospital and Cancer Center-General Campus, Ottawa, Ontario, Canada

    Contact: Study coordinator (Site Public Contact) · 613-761-4395
    Contact: Principal Investigator (Garth A. Nicholas)
  • University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada

    Contact: Study coordinator (Site Public Contact) · clinical.trials@uhn.on.ca · 416-946-4501
    Contact: Principal Investigator (Abdulazeez Salawu)
  • CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ), Québec, Quebec, Canada

    Contact: Study coordinator (Site Public Contact) · rechclinique@crchuq.ulaval.ca
    Contact: Principal Investigator (Christopher Lemieux)
  • Pan American Center for Oncology Trials LLC - Dorado, Dorado, Puerto Rico

    Contact: Study coordinator (Site Public Contact) · info@panoncologytrials.com · 787-407-3333
    Contact: Principal Investigator (Marcia R. Cruz-Correa)
  • Pan American Center for Oncology Trials LLC, San Juan, Puerto Rico

    Contact: Study coordinator (Site Public Contact) · marcia.cruzcorrea@panoncologytrials.com · 787-407-3333
    Contact: Principal Investigator (Marcia R. Cruz-Correa)
  • Pan American Center for Oncology Trials LLC - Ciudadela, San Juan, Puerto Rico

    Contact: Study coordinator (Site Public Contact) · info@panoncologytrials.com · 787-407-3333
    Contact: Principal Investigator (Marcia R. Cruz-Correa)
מובילי המחקר
  • Seth M Pollack

    Principal Investigator

    ECOG-ACRIN Cancer Research Group